EXOZYMES INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
EXOZ on Nasdaq
Location
Monrovia, CA
Fiscal year end
31 December
Latest financial report
30 Mar 2026

Latest SEC snapshot (2026-03-29) highlights Return On Equity -132.6%, Return On Assets -63.9%, and Operating Margin 0.0%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

34.9/100

Weak Confidence medium

Return On Equity

-133%

Metric score 0.0/100

Return On Assets

-64%

Metric score 0.0/100

Financial Health

Current Ratio
2.51x
Quick Ratio
2.27x
Debt to Equity
0.37x

Strengths

Current Ratio and Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-133%

YoY: +13%

Industry median: -47% (n=217)

View history

Return On Assets

-64%

YoY: +36%

Industry median: -45% (n=216)

View history

Operating Margin

0%

YoY:

Industry median: -314% (n=94)

View history

Current Ratio

2.51x

YoY: -69%

Industry median: 3.67x (n=218)

View history

Quick Ratio

2.27x

YoY:

Industry median: 2.63x (n=83)

View history

Debt-to-equity

0.37x

YoY:

Industry median: 0.28x (n=202)

View history

NetIncomeLoss YoY

-56%

YoY:

Industry median: -9.9% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -133% +13%
Return On Assets -64% +36%
Operating Margin 0%

Financial Health

Metric Latest value YoY change
Current Ratio 2.51x -69%
Quick Ratio 2.27x
Debt-to-equity 0.37x

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -56%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 8,478,992 +1.3%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%